D3 dopamine receptor mRNA expression in lymphocytes: a peripheral marker for schizophrenia?

2003 ◽  
Vol 15 (2) ◽  
pp. 91-93 ◽  
Author(s):  
J. van der Weide ◽  
L. S. W. Steijns ◽  
M. A. M. van der Geld ◽  
P. A. de Groot

Background:Identification of schizophrenia, a common neuropsychiatric disorder, is based on clinical examination. An easily measurable peripheral marker, which may enable a more rapid and more accurate diagnosis, is not available. A possible candidate is the D3 dopamine receptor on lymphocytes.Objective:The D3 receptor is investigated for its clinical significance as a marker for diagnosing schizophrenia.Methods:From eight schizophrenic patients and eight controls lymphocyte RNA was isolated. A semiquantitative reverse transcription–polymerase chain reaction (RT-PCR) was carried out and the intensities of the specific D3 dopamine receptor bands of patients and controls were compared.Results:No difference could be seen between the intensities of the bands from patients and controls.Conclusion:An aberrant D3 dopamine receptor mRNA expression in lymphocytes of schizophrenics could not be demonstrated. This might be caused by down-regulation of D3 receptor production by antipsychotic drug treatment. At present, the D3 receptor seems to have no diagnostic value in schizophrenia.

2001 ◽  
Vol 2 (1) ◽  
Author(s):  
Yong T Kwak ◽  
Min-Seong Koo ◽  
Chul-Hee Choi ◽  
IN Sunwoo

2007 ◽  
Vol 25 (18_suppl) ◽  
pp. 14120-14120
Author(s):  
K. Uchida ◽  
K. Hayashi ◽  
K. Kudo ◽  
H. Kuramochi ◽  
M. Yamamoto

14120 Background: Fluoropyrimidines are widely used in chemotherapy regimens for esophageal cancer. To test the hypotheses of whether the relative mRNA expression of the enzyme TS, DPD and MDR-1 were associated with response to in esophageal cancer. We investigated the associations reported between intratumoral TS, DPD and MDR-1 gene expressions and the response with 5-FU based chemotherapy for patients with esophageal cancer. Methods: Twenty six pts with esophageal cancer were treated with 5-FU based chemotherapy (14 pts were treated with chemotherapy only, and 12 pts were chemoradiotherapy). mRNA was isolated from frozen tumor specimens, and relative expression levels of each gene/β-actin were measured using a quantitative reverse transcription polymerase chain reaction (RT-PCR) (Taqman®) system. Results: The overall response rate was 50.0%. Each mRNA expression was detectable in 26 patients. TS expressions were significantly lower in the responding tumors compared to the non-responders respectively (P=0.009). There were no significant associations between MDR-1 expression and the response. By setting up a cut-off level for TS and MDR-1 of Median, combining the two gene expression two-dimensionally revealed a relationship with the response (P=0.037). Additionally, MDR-1 expressions were statistically significant predictors of prolonged survival (P=0.0084). Conclusions: These results suggest that intratumoral TS and MDR-1 expressions are prognostic factors for survival after 5-FU based chemotherapy in esophageal cancer. No significant financial relationships to disclose.


1996 ◽  
Author(s):  
Steven T. Schuschereba ◽  
Phillip D. Bowman ◽  
Veronica Ujimore ◽  
Stephen W. Hoxie ◽  
Jose M. Pizarro ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document